Tag: progression-free survival

A Japanese historical cohort study reconstructed progression-free survival of 3.5 months in 75 atezolizumab-treated lung cancer patients from unstructured electronic ...

An early study of 28 Korean DLBCL patients found that positive Deauville 4–5 findings on post-CAR T-cell PET/CT scans were ...

A prospective study of 48 patients links dual-tracer FDG and FAPI-04 PET/CT measurements to aggressive pathological features and survival in ...

A new study finds that elevated serum miR-424-3p is an independent prognostic marker for colorectal cancer, linked to suppression of ...

A retrospective Indian analysis of 101 patients reports real-world efficacy and safety outcomes for the trastuzumab emtansine biosimilar UJVIRA in ...

A new review finds that combining immune-checkpoint inhibitors with locoregional therapies improves progression-free survival in hepatocellular carcinoma, but overall survival ...

A multicenter retrospective study reports that a fusion model combining MRI habitat radiomics, Vision Transformer deep learning features and clinical ...

A retrospective study of 56 Chinese patients aged 60 and older found PD-1 inhibitor rechallenge after prior immunotherapy produced a ...

A combined gut microbiome score linking probiotic-associated bacteria and butyrate production capacity was associated with early resistance to anti-PD-1 therapy ...

A retrospective study of 125 advanced sarcoma patients found molecular tumor board recommendations led to treatment in 32.8 percent, with ...

A retrospective single-center study of 75 treatment-naive CLL/SLL patients reports an 86.7% response rate with frontline orelabrutinib monotherapy and no ...

A phase 2 trial reports that camrelizumab plus famitinib produced tumor shrinkage in 42.9 percent of patients with advanced pulmonary ...

A spatial transcriptomics study links depletion of non-tumoral B cells to relapse risk in classical Hodgkin lymphoma and introduces an ...

An AI-based digital pathology assessment of PD-L1 identified metastatic triple-negative breast cancer patients with longer progression-free survival on pembrolizumab in ...

A single-center study of 21 patients found that trastuzumab emtansine produced no responses and a median progression-free survival of 2.20 ...

A retrospective study of 45 hepatocellular carcinoma patients found that intratumoral tertiary lymphoid structures were associated with disease control and ...

A meta-analysis of sixteen studies found that CT-defined sarcopenia was significantly associated with poorer overall survival, progression-free survival and tumor ...

An indirect comparison finds sacituzumab govitecan and datopotamab deruxtecan comparable in progression control, but only sacituzumab govitecan has direct randomized ...

A pre-immunotherapy MIBG Curie score above 3 independently predicts poorer progression-free survival in children with high-risk neuroblastoma receiving anti-GD2 immunotherapy.

A retrospective two-center study reports a four-variable nomogram that estimates five-year progression-free survival in differentiated thyroid cancer patients with lung ...